A novel microRNA signature associated with cisplatin resistant NSCLC holds both diagnostic and prognostic biomarker potential

被引:0
|
作者
MacDonagh, L. [1 ,2 ]
Gray, S. G. [1 ,2 ]
Cuffe, S. [1 ,2 ]
Finn, S. P. [1 ,2 ,3 ]
Young, V. [4 ]
Ryan, R. [4 ]
Nicholson, S. [3 ]
Leonard, N. [3 ]
Sui, J. Sze Yin [1 ,2 ]
O'Byrne, K. J. [5 ]
Barr, M. P. [1 ,2 ]
机构
[1] St James Hosp, Thorac Oncol Res Grp, Inst Mol Med, Trinity Ctr Hlth Sci, Dublin 8, Ireland
[2] Univ Dublin Trinity Coll, Dublin 2, Ireland
[3] St James Hosp, Dept Histopathol, Dublin 8, Ireland
[4] St James Hosp, Dept Cardiothorac Surg, Dublin 8, Ireland
[5] Queensland Univ Technol, Canc & Ageing Res Program, Brisbane, Qld 4001, Australia
关键词
D O I
10.1016/S0169-5002(16)30022-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5
引用
收藏
页码:S2 / S3
页数:2
相关论文
共 50 条
  • [1] Big applications for a microRNA signature: the diagnostic, prognostic and predictive biomarker potential of a novel 5-miR signature associated with cisplatin resistant NSCLC
    MacDonagh, L.
    Gray, S. G.
    Gallagher, M.
    French, B.
    Gasch, C.
    Young, V.
    Ryan, R.
    Nicholson', S.
    Leonard, N.
    Finn, S. P.
    Cuffe, S.
    O'Byrne, K.
    Barr, M. P.
    LUNG CANCER, 2018, 115 : S5 - S5
  • [2] A Novel microRNA Signature Associated with Cisplatin Resistance in NSCLC
    MacDonagh, Lauren
    Gray, Steven G.
    Young, Vincent
    Ryan, Ronan
    Nicholson, Siobhan
    Leonard, Niamh
    O'Byrne, Kenneth J.
    Finn, Stephen P.
    Cuffe, Sinead
    Barr, Martin P.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S389 - S389
  • [3] A Novel 5-miR Signature Shows Potential as a Diagnostic Tool and as a Predictive Biomarker of Cisplatin Response in NSCLC
    Mac Donagh, L.
    Gray, S.
    Gallagher, M.
    Ffrench, B.
    Gasch, C.
    Young, V.
    Ryan, R.
    Nicholson, S.
    Leonard, N.
    Finn, S.
    Cuffe, S.
    O'Byrne, K.
    Barr, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2122 - S2122
  • [4] Identification of a novel microRNA signature: Potential diagnostic biomarkers and predictors of cisplatin response?
    Barr, M. P.
    MacDonagh, L.
    Gray, S. G.
    Reidy, M.
    Sui, J. Sze Yin
    Nicholson, S.
    Leonard, N.
    O'Byrne, K.
    Cuffe, S.
    Finn, S.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S85 - S85
  • [5] Novel Prognostic Biomarker Using MicroRNA Signature of Breast Cancer
    Kawaguchi, T.
    Yan, L.
    Qi, Q.
    Liu, S.
    Takabe, K.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S57 - S57
  • [6] microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers
    Gasparini, Pierluigi
    Cascione, Luciano
    Fassan, Matteo
    Lovat, Francesca
    Guler, Gulnur
    Balci, Serdar
    Irkkan, Cigdem
    Morrison, Carl
    Croce, Carlo M.
    Shapiro, Charles L.
    Huebner, Kay
    ONCOTARGET, 2014, 5 (05) : 1174 - 1184
  • [7] MicroRNA Signature of Malignant Mesothelioma with Potential Diagnostic and Prognostic Implications
    Busacca, Sara
    Germano, Serena
    De Cecco, Loris
    Rinaldi, Maurizio
    Comoglio, Federico
    Faverot, Francesco
    Murer, Bruno
    Mutti, Luciano
    Pierotti, Marco
    Gaudino, Giovanni
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2010, 42 (03) : 312 - 319
  • [8] MicroRNA-15a is a Potential Circulating Biomarker of Abdominal Aortic Aneurysm With Both Diagnostic and Prognostic Properties
    Winski, Greg
    Eken, Suzanne M.
    Chernogubova, Ekaterina
    Busch, Albert
    Jin, Hong
    Winter, Hanna
    Spin, Joshua
    Backlund, Alexandra
    Tsao, Philip S.
    Maegdefessel, Lars
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2020, 40
  • [9] The role of MicroRNA as a potential diagnostic and prognostic biomarker for cerebral aneurysms
    Al-Jehani, Hosam M.
    Turkistani, Alaa N.
    Alrayes, Majd M.
    AlHamid, May A.
    AlShamikh, Arwa S.
    Al Sadah, Zhra M.
    Alabbas, Faisal M.
    Cyrus, Cyril
    Al-Ali, Amein K.
    NEUROSCIENCES, 2023, 28 (04) : 250 - 257
  • [10] Serum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapy
    En-hai Cui
    Hong-jiao Li
    Feng Hua
    Bin Wang
    Wei Mao
    Xue-ren Feng
    Jian-you Li
    Xiang Wang
    Acta Pharmacologica Sinica, 2013, 34 : 309 - 313